Mupirocin - Generic Drug Details

✉ Email this page to a colleague

What are the generic sources for mupirocin and what is the scope of freedom to operate?

Mupirocin is the generic ingredient in three branded drugs marketed by Glaxosmithkline, Padagis Us, Fougera Pharms, Glenmark Pharms, Padagis Israel, Taro, Teva, Alembic, Amneal, Encube, and Glenmark Pharms Inc, and is included in fifteen NDAs. Additional information is available in the individual branded drug profile pages.

There are sixteen drug master file entries for mupirocin. Twenty suppliers are listed for this compound.

Sponsor	Phase
Jiangxi Provincial Cancer Hospital	Phase 3
Future University in Egypt	Phase 2/Phase 3
Nantes University Hospital	Phase 2

Sponsor

Phase

Jiangxi Provincial Cancer Hospital

Phase 3

Future University in Egypt

Phase 2/Phase 3

Nantes University Hospital

Phase 2

US Patents and Regulatory Information for mupirocin

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Encube	MUPIROCIN	mupirocin calcium	CREAM;TOPICAL	213076-001	Aug 31, 2021	AB	RX	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Padagis Israel	MUPIROCIN	mupirocin	OINTMENT;TOPICAL	065123-001	Nov 7, 2003	AB	RX	No	Yes	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Glenmark Pharms Inc	MUPIROCIN	mupirocin calcium	CREAM;TOPICAL	201587-001	Jan 24, 2013	AB	RX	No	Yes	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Glaxosmithkline	BACTROBAN	mupirocin	OINTMENT;TOPICAL	050591-001	Dec 31, 1987		DISCN	Yes	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Fougera Pharms	MUPIROCIN	mupirocin	OINTMENT;TOPICAL	065192-001	Nov 30, 2005	AB	RX	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Alembic	MUPIROCIN	mupirocin calcium	CREAM;TOPICAL	213053-001	Nov 16, 2021	AB	RX	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Glenmark Pharms	MUPIROCIN	mupirocin	OINTMENT;TOPICAL	090480-001	Jun 8, 2011	AB	RX	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Padagis Us	CENTANY	mupirocin	OINTMENT;TOPICAL	050788-001	Dec 4, 2002	⤷ Try a Trial	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Applicant

Tradename

Generic Name

Dosage

NDA

Approval Date

Patent No.

Patent Expiration

OINTMENT;TOPICAL

Dec 4, 2002

>Applicant

>Tradename

>Generic Name

>Dosage

>NDA

>Approval Date

>Patent No.

>Patent Expiration

Subscribe to access the full database, or Try a Trial

US Patents:	0
Tradenames:	3
Applicants:	11
NDAs:	15
Drug Master File Entries:	16
Finished Product Suppliers / Packagers:	20
Raw Ingredient (Bulk) Api Vendors:	87
Clinical Trials:	81
Patent Applications:	6,502
Formulation / Manufacturing:	see details
Drug Prices:	Drug price trends for mupirocin
Drug Sales Revenues:	Drug sales revenues for mupirocin
What excipients (inactive ingredients) are in mupirocin?	mupirocin excipients list
DailyMed Link:	mupirocin at DailyMed

Drug Class	RNA Synthetase Inhibitor Antibacterial
Mechanism of Action	RNA Synthetase Inhibitors

Mupirocin - Generic Drug Details

What are the generic sources for mupirocin and what is the scope of freedom to operate?

Summary for mupirocin

Recent Clinical Trials for mupirocin

Pharmacology for mupirocin

Medical Subject Heading (MeSH) Categories for mupirocin

US Patents and Regulatory Information for mupirocin

Expired US Patents for mupirocin

Make Better Decisions: Try a trial or see plans & pricing